Phylogica, Pepscan form research pact
As per the terms of the research collaboration and option agreement, Pepscan will utilize its Chemical LInkage of Peptides onto Scaffolds (CLIPS) technology for optimizing novel therapeutic Phylomer
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.